Kluender; Harold C. E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kluender; Harold C. E..The latest application filed is for "pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis".

Company Profile

0.12.18

Kluender; Harold C. E. - Hartland WI US
Kluender; Harold C.E. - Trumbull CT
Kluender, Harold C E - Trumbull CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,829,185 - Dixon , et al. September 9, 2	2014-09-09
Pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20130225809 - Dixon; Julie A. ; et al.	2013-08-29
Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,338,595 - Dixon , et al. December 25, 2	2012-12-25
Substituted 4-amino-pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20120165314 - Dixon; Julie ; et al.	2012-06-28
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,143,393 - Dixon , et al. March 27, 2	2012-03-27
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,129,379 - Dixon , et al. March 6, 2	2012-03-06
Substituted Pyridines And Pyridazines With Angiogenesis Inhibiting Activity App 20110263597 - Dumas; Jacques P. ; et al.	2011-10-27
Substituted pyridines and pyridazines with angiogenesis inhibiting activity Grant 7,977,333 - Dumas , et al. July 12, 2	2011-07-12
Substituted 4-amino-pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20100179125 - Dixon; Julie A. ; et al.	2010-07-15
Pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20100075958 - Dixon; Julie A. ; et al.	2010-03-25
Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 7,563,791 - Dixon , et al. July 21, 2	2009-07-21
1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents App 20090023753 - Chuang; Chih-Yuan ; et al.	2009-01-22
2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents App 20080293696 - Brennan; Catherine ; et al.	2008-11-27
Pyrrolotriazine Derivatives Useful For Treating Hyper-Proliferative Disorders And Diseases Associated With Angiogenesis App 20070208013 - Dixon; Julie A. ; et al.	2007-09-06
Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesity App 20060122215 - Smith; Roger A. ; et al.	2006-06-08
Hydroxamic acids useful in the treatment of hyper-proliferative disorders App 20060063760 - Wang; Yamin ; et al.	2006-03-23
Preparation and use of imidazole derivatives for treatment of obesity App 20050256167 - Smith, Roger A. ; et al.	2005-11-17
Preparation and use of imidazole derivatives for treatment of obesity Grant 6,960,601 - Smith , et al. November 1, 2	2005-11-01
Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity Grant 6,903,101 - Dumas , et al. June 7, 2	2005-06-07
Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives App 20050019424 - Adams, Paul E. ; et al.	2005-01-27
Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity App 20040224970 - Smith, Roger A ; et al.	2004-11-11
Pyrazole derivatives useful in the treatment of hyper-proliferative disorders App 20040180891 - Khire, Uday ; et al.	2004-09-16
Substituted pyridines and pyridazines with angiogenesis inhibiting activity App 20040092740 - Dumas, Jacques P. ; et al.	2004-05-13
Preparation and use of imidazole derivatives for treatment of obesity App 20040063691 - Smith, Roger A. ; et al.	2004-04-01
Substituted pyridines and pyridazines with angiogenesis inhibiting activity Grant 6,689,883 - Dumas , et al. February 10, 2	2004-02-10
Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents App 20030229072 - Bullock, William H ; et al.	2003-12-11
Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents App 20030207865 - Dixon, Brian R. ; et al.	2003-11-06
Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents Grant 6,353,006 - Dixon , et al. March 5, 2	2002-03-05
Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors Grant 5,939,583 - Kluender , et al. August 17, 1	1999-08-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.